Houston’s translational moment looks beyond its clinical prowess
The city has a dedicated effort to turn its clinical depth, manufacturing and capital into a repeatable path from discovery to medicines
Houston has long been recognized for its scale. Now it’s biotech’s turn to be the beneficiary. Anchored by the world’s largest medical complex, the city boasts educational, scientific, and clinical resources. But as it seeks to establish itself as a hub, it needs to create an infrastructure for translation, which means growing the connectivity among the composite parts.
At Helix Park, new spaces are bringing researchers, entrepreneurs, investors, and industry partners together at the doorstep of Texas Medical Center. At the TMC Innovation Factory, founders are gaining access to the networks and resources needed to turn discoveries into companies. At Rice University, a growing venture studio is pairing faculty and students with seasoned operators and investors to spin out fundable Houston-built biotechs...